There are many articles recently regarding Fucosylation authored by researchers at Seattle Genetics. They have also been getting patents on their products. I gather it is all part if their engineered sugar technologies, but most of this research is well beyond my comprehension. The ASH abstract appears interesting as the SGN engineered sugar does markedly inhibit vaso occlusion in Sickle Cell mice without any toxicity observed .
If you Google some of the key words their is a lot of recent literature but like I said , beyond my comprehension level.
atpl1959, Thanks so much for your kind reply to my inquiry. I am somewhat familiar with the SGEN sugar engineering technology as it pertain to antibody enhancement. However, this is the first I have heard or seen regarding anything to do with sickle cell. Ricardo.